| Symbol | AURA |
|---|---|
| Name | AURA BIOSCIENCES, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Address | 80 GUEST STREET, BOSTON, Massachusetts, 02135, United States |
| Telephone | +1 617 500-8864 |
| Fax | — |
| — | |
| Website | https://www.aurabiosciences.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001501796 |
| Description | Aura Biosciences Inc is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system to create long-lasting anti-tumor immunity. Additional info from NASDAQ: |
Bender Jeremy 🟢 acquired 90.0K shares (1 derivative) of Aura Biosciences, Inc. (AURA) at $7.03 Transaction Date: Jul 07, 2026 | Filing ID: 298542
Read moreNew Form 3 - Aura Biosciences, Inc. <b>Filed:</b> 2026-07-08 <b>AccNo:</b> 0001193125-26-298538 <b>Size:</b> 15 KB
Read more(98% Positive) AURA BIOSCIENCES, INC. (AURA) Announces Enrollment Update for time Due to Patient Enrollment Issues, Regulatory Process
Read moreAura Biosciences Announces Appointment of Jeremy Bender, Ph.D., M.B.A., to Board of Directors
Read moreNew Form DEF 14A - Aura Biosciences, Inc. <b>Filed:</b> 2026-06-29 <b>AccNo:</b> 0001193125-26-288498 <b>Size:</b> 2 MB
Read moreNew Form PRE 14A - Aura Biosciences, Inc. <b>Filed:</b> 2026-06-17 <b>AccNo:</b> 0001193125-26-274232 <b>Size:</b> 2 MB
Read more📋 Gibney Anthony (Officer) plans to sell 13K shares of Aura Biosciences, Inc. (at $6.42 each, total $82K) Filed: Jun 16, 2026 | ID: 272705
Read moreGibney Anthony S 🔴 sold 12.8K shares of Aura Biosciences, Inc. (AURA) at $6.42 Transaction Date: Jun 16, 2026 | Filing ID: 272703
Read moreBitetti Teresa Marie 🟢 acquired 45.0K shares (1 derivative) of Aura Biosciences, Inc. (AURA) at $6.21 Transaction Date: Jun 11, 2026 | Filing ID: 271171
Read moreSrivastava Sapna 🟢 acquired 45.0K shares (1 derivative) of Aura Biosciences, Inc. (AURA) at $6.21 Transaction Date: Jun 11, 2026 | Filing ID: 271170
Read more